During the recent session, Roivant Sciences Ltd (NASDAQ:ROIV)’s traded shares were 1.38 million, with the beta value of the company hitting 1.16. The 52-week high for the ROIV share is $13.06, that puts it down -14.16 from that peak though still a striking 23.69% gain since the share price plummeted to a 52-week low of $8.73. The company’s market capitalization is $7.77B, and the average intraday trading volume over the past 10 days was 5.61 million shares, and the average trade volume was 6.68 million shares over the past three months.
Roivant Sciences Ltd (ROIV) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.20. ROIV has a Sell rating from 0 analyst(s) out of 7 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 7 recommend a Buy rating for it.
Roivant Sciences Ltd (NASDAQ:ROIV) trade information
Roivant Sciences Ltd (ROIV) registered a -0.04% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -0.04% in intraday trading to $11.44, hitting a weekly high. The stock’s 5-day price performance is -0.31%, and it has moved by 3.58% in 30 days. Based on these gigs, the overall price performance for the year is 6.67%. The short interest in Roivant Sciences Ltd (NASDAQ:ROIV) is 44.43 million shares and it means that shorts have 8.32 day(s) to cover.
The consensus price target of analysts on Wall Street is $17, which implies an increase of 32.71% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $12.5 and $20 respectively. As a result, ROIV is trading at a discount of -74.83% off the target high and -9.27% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -99.51%. While earnings are projected to return -397.62% in 2025.
ROIV Dividends
Roivant Sciences Ltd is due to release its next quarterly earnings on 2025-May-29. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Roivant Sciences Ltd (NASDAQ:ROIV)’s Major holders
Roivant Sciences Ltd insiders own 30.85% of total outstanding shares while institutional holders control 83.50%, with the float percentage being 120.75%. SB INVESTMENT ADVISERS (UK) LTD is the largest shareholder of the company, while 409.0 institutions own stock in it. As of 2024-06-30, the company held over 71.36 million shares (or 9.6983% of all shares), a total value of $754.29 million in shares.
The next largest institutional holding, with 69.16 million shares, is of VIKING GLOBAL INVESTORS LP’s that is approximately 9.3985% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $730.98 million.
